First Manhattan CO Ascendis Pharma A/S Transaction History

First Manhattan CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $7.87 Million - $12.4 Million	-69,849 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $1.17 Million - $1.4 Million	-9,659 Reduced 12.15%	69,849 $9.19 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $1.76 Million - $2.44 Million	-14,092 Reduced 15.06%	79,508 $10.2 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $288,262 - $405,626	-2,600 Reduced 2.7%	93,600 $13.8 Million
Q1 2020 May 06, 2020	BUY	$97.01 - $145.11 $164,917 - $246,687	1,700 Added 1.8%	96,200 $10.8 Million
Q4 2019 Feb 13, 2020	BUY	$91.45 - $139.12 $2.01 Million - $3.06 Million	22,000 Added 30.34%	94,500 $13.1 Million
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $239,500 - $297,250	-2,500 Reduced 3.33%	72,500 $6.98 Million
Q1 2019 Apr 12, 2019	SELL	$62.15 - $129.99 $10.5 Million - $21.9 Million	-168,306 Reduced 69.17%	75,000 $8.83 Million
Q4 2018 Jan 30, 2019	SELL	$55.16 - $69.67 $1.65 Million - $2.09 Million	-29,931 Reduced 10.95%	243,306 $15.2 Million
Q3 2018 Oct 15, 2018	SELL	$63.77 - $76.28 $5.24 Million - $6.26 Million	-82,111 Reduced 23.11%	273,237 $19.4 Million
Q3 2017 Oct 25, 2017	BUY	$26.89 - $37.1 $9.56 Million - $13.2 Million	355,348	355,348 $12.9 Million

243

59.6M

80.3K

216K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $9.51B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.